Continuous intraperitoneal insulin infusion versus subcutaneous insulin for type 1 diabetes: a prospective, case-control trial proving non-inferiority

被引：0
|
作者：
Bilo, H. J. G. [1 ]
van Dijk, P. R. [1 ]
Logtenberg, S. J. J. [1 ]
Groenier, K. H. [1 ]
Feenstra, H. [2 ]
Gans, R. O. B. [3 ]
Kleefstra, N. [1 ]
机构：
[1] Isala Clincs, Ctr Diabet, Zwolle, Netherlands
[2] Diaconessenhuis, Meppel, Netherlands
[3] Univ Med Ctr Groningen, Groningen, Netherlands
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
193
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [31] Successful Treatment of Type 1 Diabetes With Intraperitoneal Insulin Infusion when Subcutaneous Insulin Application is not Possible: Two Case Reports
    Liebl, Andreas
    Gehr, Berhard
    Bacher, Franziska
    Kiehling, Claus
    Frei, Thomas
    DIABETES, 2012, 61 : A230 - A231
  • [32] Reassessment of Insulin Dosing Guidelines in Continuous Subcutaneous Insulin Infusion Treated Type 1 Diabetes
    King, Allen Bennett
    CURRENT DIABETES REPORTS, 2014, 14 (06)
  • [33] Reassessment of Insulin Dosing Guidelines in Continuous Subcutaneous Insulin Infusion Treated Type 1 Diabetes
    Allen Bennett King
    Current Diabetes Reports, 2014, 14
  • [34] Continuous subcutaneous insulin infusion is relevant in reducing insulin requirement in patients with type 1 diabetes
    Pankowska, E.
    Blazik, M.
    Groele, L.
    DIABETOLOGIA, 2011, 54 : S399 - S399
  • [35] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY DECREASES INSULIN RESISTANCE IN TYPE-1 DIABETES
    YKIJARVINEN, H
    KOIVISTO, VA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (04): : 659 - 666
  • [36] Intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: preliminary results of a prospective randomized cross-over trial
    van Ballegooie, E.
    Logtenberg, S. J. J.
    Kleefstra, N.
    Houweling, S. T.
    Groenier, K. H.
    Bilo, H. J. G.
    DIABETOLOGIA, 2007, 50 : S97 - S98
  • [37] INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART
    Thrasher, James
    Bhargava, Anuj
    Rees, Tina M.
    Wang, Tao
    Guzman, Cristina B.
    Glass, Leonard C.
    ENDOCRINE PRACTICE, 2015, 21 (03) : 247 - 257
  • [38] Intraperitoneal versus subcutaneous insulin therapy in the treatment of type 1 diabetes mellitus
    van Dijk, P. R.
    Logtenberg, S. J. J.
    Hendriks, S. H.
    Groenier, K. H.
    Feenstra, J.
    Pouwer, F.
    Gans, R. O. B.
    Kleefstra, N.
    Bilo, H. J. G.
    NETHERLANDS JOURNAL OF MEDICINE, 2015, 73 (09):
  • [39] Continuous subcutaneous insulin infusion improves glycemic control and quality of life in type 1 diabetes
    Carol Lovegrove
    Nature Clinical Practice Endocrinology & Metabolism, 2005, 1 (2): : 64 - 64
  • [40] The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes
    Azevedo, Sergio
    Saraiva, Joana
    Caramelo, Francisco
    Fadiga, Lucia
    Barros, Luisa
    Baptista, Carla
    Melo, Miguel
    Gomes, Leonor
    Carrilho, Francisco
    ACTA MEDICA PORTUGUESA, 2019, 32 (01) : 17 - 24
12345